$NVET Nexvet Biopharma plc Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nexvet Biopharma plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Nexvet Biopharma plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Nexvet Biopharma plc for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NVET
Company Address: UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY R35 FR98
Former name: NEXVET BIOPHARMA Ltd, date of change: 2014-09-03
Market Capitalization: $40.45M
Prev close: $3.20
Average Daily Volume: 10,437
Days Low: $3.28
Year Low: $2.61
Year High: $5.70
Nexvet Biopharma plc Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | PAYNE JOHN BERNARD | Director | Sell | D | 6.72 | 6,195 | 41,630 | 0 | 6.2 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | PAYNE JOHN BERNARD | Director | Sell | D | 6.72 | 10,800 | 72,576 | 0 | 10.8 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Sell | D | 6.72 | 16,400 | 110,208 | 0 | 16.4 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Option Exercise | D | 15.00 | 100,000 | 1,500,000 | 0 | |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Option Exercise | D | 0.13 | 48,750 | 6,094 | 0 | |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Option Exercise | D | 0.13 | 27,500 | 3,438 | 0 | |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Sell | D | 6.72 | 18,724 | 125,825 | 0 | 18.7 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Sell | D | 6.72 | 21,239 | 142,726 | 0 | 21.2 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Sell | D | 6.72 | 67,750 | 455,280 | 0 | 67.8 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Kilty Cormac G | Director | Sell | D | 6.72 | 144,364 | 970,126 | 0 | 144.4 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Kilty Cormac G | Director | Sell | D | 6.72 | 10,800 | 72,576 | 0 | 10.8 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | HORN JURGEN | Chief Product Devel ... | Option Exercise | D | 0.13 | 47,250 | 5,906 | 0 | |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | HORN JURGEN | Chief Product Devel ... | Option Exercise | D | 5.10 | 60,000 | 306,000 | 0 | |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | HORN JURGEN | Chief Product Devel ... | Sell | D | 6.72 | 15,750 | 105,840 | 0 | 15.8 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | Heffernan Mark | Chief Executive Off ... | Option Exercise | D | 15.00 | 100,000 | 1,500,000 | 0 |